Carrier screening for Cystic Fibrosis among maryland obstetricians before and after the 1997 NIH Consensus Conference

Genetic Testing

Volumn 5, Issue 2, 2001, Pages 111-116

  Doksum, T ^a   Bernhardt, B A ^a   Holtzman, N A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CYSTIC FIBROSIS; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MALE; OBSTETRICS; PATIENT EDUCATION; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; QUESTIONNAIRE; UNITED STATES;

EID: 0034863768     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065701753145565     Document Type: Article

References (22)

1. Statement of the American Society of Human Genetics on cystic fibrosis carrier screening
2. Physician attitudes on CF carrier detection: Incorporating genetic testing into routine care
3. Family values and resistance to genetic testing
4. The impact of clinical guidelines on practice patterns: Doing more versus doing less
5. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening
6. Population-based carrier screening for cystic fibrosis
7. Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening
8. Barriers to carrier testing for adult cystic fibrosis sibs: The importance of not knowing
9. A qualitative assessment of primary care physicians' perceptions about the ethical and social implications of offering genetic testing
10. Decision-making about breast cancer susceptibility testing: How similar are the attitudes of physicians, nurse practitioners, and at-risk women?
11. Physicians' knowledge of genetics and genetic tests
12. Cystic fibrosis carrier population screening in the primary care setting
13. Cystic fibrosis carrier screening: Knowledge and attitudes of prenatal care providers
14. Factors influencing health insurers' decisions to cover new genetic technologies
15. Cystic fibrosis carrier screening practices in an ethnically diverse region: Experience of the genetic network of the Empire State, Puerto Rico, and the U.S. Virgin Islands
16. Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing
17. Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization
18. The introduction of cystic fibrosis carrier screening into clinical practice: Policy considerations